Revenue growth target of 30%+
Management guided that 30% revenue growth is easily achievable and they are being 'bit conservative' with this number for FY26.
Yatharth Hospital & Trauma Care Services · forward-looking guidance across the available source record.
Guidance tracker
Management guided that 30% revenue growth is easily achievable and they are being 'bit conservative' with this number for FY26.
Management maintained 40,000 ARPO target for FY28 with 8-10% annual ARPO growth expected, to be driven by Delhi/Faridabad ramping with oncology, transplant, and international patient mix.
New CGHS rates effective October 2025 will contribute ~1% benefit in FY26 and ~2.5% to overall revenue from FY27 onwards, given 37% government revenue mix and some exclusions like ECHS.
Shanti Vid Hospital (250 beds, running facility with ARPO ~₹30,000+) to be on books from Q4 with full integration expected by H2, contributing positively from day one.
Management explicitly stated Q4 will be better than Q3 driven by full-quarter impact of CDHS price revision (from January 1, 2026) and reduced losses from new hospitals as occupancy ramps.
With ongoing new hospital additions, management guides blended EBITDA margins in the 24-25% range on consolidated level for FY27, noting mature hospital margins (excluding new hospitals) at ~29%.
Announced deals within 3-3.5 years with ₹1,500 crore total capex (~₹60 lakh per bed) over 5-year deployment period. Mix of greenfield, brownfield, and asset-light expansion in NCR and major North Indian cities.
Management targets reducing government business from current 35% to 25-28% through strategic focus on cash and private insurance, particularly in new hospitals where government mix will be capped at 15-20%.